Population-Based Assessment of Patient-Reported Cosmetic Outcomes in Older Breast Cancer Survivors

C. W. Swanick,X. Lei,Y. Xu,Y. Shen,N. A. Goodwin,S. H. Giordano,K. K. Hunt,A. L. Pusic,R. Jagsi,S. F. Shaitelman,S. K. Peterson,B. D. Smith

DOI: https://doi.org/10.1016/j.ijrobp.2016.06.630

2016-01-01

Abstract:For older women with non-metastatic breast cancer, local treatment options include (1) lumpectomy followed by whole breast irradiation (Lump + WBI), (2) lumpectomy followed by brachytherapy (Lump + Brachy), (3) lumpectomy followed by endocrine therapy alone without radiation (Lump alone), (4) mastectomy without radiation (Mast alone), or (5) mastectomy followed by radiation (Mast + RT). For many patients, several of these options are acceptable based on current guidelines, but little is known about the impact of treatment choice on long-term quality of life outcomes such as cosmesis. We surveyed a population-based cohort of older breast cancer survivors treated with one of these five options to assess patient satisfaction with cosmetic outcome. We used nationally comprehensive Medicare claims to identify women age ≥67 diagnosed with non-metastatic breast cancer in 2009, treated with one of these five treatment options, and still alive in 2015. From this cohort, 1650 patients (330 patients per local treatment) were randomly selected by applying Probability Proportional to Size sampling. Of these, 397 opted out, leaving 1253 potential participants. In November 2015, all potential participants were mailed a survey that included the CanSORT Satisfaction with Breast Cosmetic Outcomes instrument (5-point Likert scale, higher score indicates better outcome). A multivariable linear regression model was used to assess the association of local treatment with cosmetic outcome, adjusting for age, race, comorbidity, chemotherapy receipt, geographic region, and area-level socioeconomic covariables. All analyses incorporated weights to account for sample selection. To date, we have received completed surveys from 431 women (26% response rate to date, additional mail-outs are ongoing). Median age is 72 years (range 67-87). The mean cosmesis score by treatment group was 3.67 for Lump + WBI (n = 97), 3.97 for Lump + Brachy (n = 97), 3.82 for Lump alone (n = 65), 3.32 for Mast alone (n = 79), and 3.26 for Mast + RT (n = 93). In multivariable analysis with Lump + WBI as the referent group, adjusted satisfaction score was 0.34 points higher for Lump + Brachy (P = 0.02), and 0.43 points lower for Mast + RT (P = 0.01). The adjusted satisfaction score was 0.32 points lower for Mast alone, but the difference was marginally significant (P = 0.053). The difference in satisfaction between Lump + WBI and Lump alone was not statistically significant (P = 0.20). In this preliminary sample of a population-based cohort of Medicare beneficiaries, patient-reported satisfaction with cosmetic outcome was higher among patients treated with lumpectomy followed by brachytherapy and lower for those treated with mastectomy compared to those treated with lumpectomy followed by WBI. Comparative description of patient cosmetic outcomes with accepted treatment approaches in large population-based samples treated in diverse settings is necessary to inform patient treatment decisions.